The MTHFR promoter hypermethylation pattern associated with the A1298C polymorphism influences lipid parameters and glycemic control in diabetic patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Satyanarayana A, Balakrishna N, Pitla S, et al. Status of B-vitamins and homocysteine in diabetic retinopathy: association with vitamin-B12 deficiency and hyperhomocysteinemia. PLoS ONE. 2011;6(11):e26747.
Li Y, Zhang H, Jiang C, et al. Hyperhomocysteinemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem. 2013;288(14):9583–92.
Buysschaert M, Dramais AS, Wallemacq PE, Hermans MP. Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance. Diabetes Care. 2000;23(12):1816–22.
Hoffman DR, Cornatzer WE, Duerre JA. Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. Can J Biochem. 1979;57(1):56–65.
Dos Santos Nunes MK, Silva AS, Queiroga IW, et al. Hypermethylation in the promoter of the MTHFR gene is associated with diabetic complications and biochemical indicators. Diabetol Metab Syndr. 2017;9:84.
Maeda M, Yamamoto I, Fukuda M, et al. MTHFR gene polymorphism is susceptible to diabetic retinopathy but not to diabetic nephropathy in Japanese type 2 diabetic patients. J Diab Compli. 2008;22(2):119–25.
Settin A, El-Baz R, Ismaeel A, Tolba W, Alá WA. Association of ACE and MTHFR genetic polymorphisms with type 2 diabetes mellitus: susceptibility and complications. J Renin Angiot Aldosterone. 2015;16(4):838–43.
Cui WP, Du B, Jia Y, et al. Is C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabeticnephropathy or diabetes mellitus in a Chinese population? Arch Med Res. 2012;43(1):42–50.
Yang S, Zhang J, Feng C, Huang L. MTHFR 677T variant contributes to diabetic nephropathy risk in Caucasian individuals with type 2 diabetes: a meta-analysis. Metabolism. 2013;62(4):586–94.
Jafari Y, Rahimi Z, Vaisi- Raygani A, Rezaei M. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem. 2011;353(1–2):23–34.
El- Baz R, Settin A, Ismaeel A, et al. MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients. J Renin Angiotensin Aldosterone Syst. 2012;13(4):472–7.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–3.
Van der Put NM, Gabreëls F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolatereductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62(5):1044–51.
Gaughan DJ, Barbaux S, Kluijtmans LA, Whitehead AS. The human and mouse methylenetetrahydrofolatereductase (MTHFR) genes: genomic organization, mRNA structure and linkage to the CLCN6 gene. Gene. 2000;257(2):279–89.
Wei K, Sutherland H, Camilleri E, Haupt LM, Griffiths LR, Gan SH. Computational epigenetic profiling of CpG islets in MTHFR. Mol Biol Rep. 2014;41(12):8285–92.
Yang XH, Cao RF, Yu Y, et al. A study on the correlation between MTHFR promoter methylation and diabetic nephropathy. Am J Transl Res. 2016;8(11):4960–7.
Wang L, Zhang J, Wang S. Demethylation in the promoter region of MTHFR gene and its mRNA expression in cultured human vascular smooth muscle cells induced by homocysteine. Wei Sheng Yan Jiu. 2007;36(3):291–4.
Ghattas M, El-Shaarawy F, Mesbah N, Abo-Elmatty D. DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients. Mol Biol Rep. 2014;41(2):683–8.
Li WX, Dai SX, Zheng JJ, Liu JQ, Huang JF. Homocysteine metabolism gene polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) jointly elevate the risk of folate deficiency. Nutrients. 2015;7(8):6670–87.
Paz MF, Avila S, Fraga MF, et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Can Res. 2002;62:4519–24.
Shahzad K, Hai A, Ahmed A, Kizilbash N, Alruwaili J. A structured-based model for the decreased activity of Ala222Val and Glu429Ala methylenetetrahydrofolatereductase (MTHFR) mutants. Bioinformation. 2013;9:929–36.
Friedman G, Goldschmidt N, Yechiel F. A common mutation A1298C in human methylenetetrahydrofolatereductase gene: association with plasma total homocysteine and folate concentrations. J Nutr. 1999;119(9):1656–61.
Hobbs CA, James SJ, et al. Congenital heart defects and genetic variants in the methylenetetrahydroflatereductase gene. J Med Genet. 2006;43:162–6.
Biselli PM, Guerzoni AR, de Godoy MF. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J Thromb Thrombolysis. 2010;29(1):32–40.
Safarinejad MR, Shafiei N, Safarinejad S. Methylenetetrahydrofolatereductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumourbehaviour in men. ClinOncol. 2012;24(4):269–81.
Karmin O, Lynn EG, Chung YH, Siow YL, Man RYK, Choy PC. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. BBA. 1998;1393:317–24.
Zheng J, Cheng J, Zhang Q, Xiao X. Novel insights into DNA methylation and its critical implications in diabetic vascular complications. Biosci Rep. 2017;37(2):2016061.